Power3 Medical Products and Proteomics Get Super Coverage on Super Bowl Sunday; 'Forget the Steelers and Seahawks!' as Houston Chronicle Focuses on Scientific Research.HOUSTON -- While most Americans watched football yesterday, when Steven B. Rash walked into a Super Bowl party, his fellow Houstonians turned away from the big game and made him "feel like a star." With four articles and more than 3,000 words covering proteomics and his company, Power3 Medical Products, Inc. (PWRM PWRM Pre-Positioned War Reserve Materiel .PK), on the front business page of yesterday's Houston Chronicle, Mr. Rash said he "did everything but sign autographs" at the Super Bowl event. "Forget the Steelers and the Seahawks!" he said. "Yesterday the focus was on Power3 and our leadership in developing early-detection diagnostic tests for cancer and neurodegenerative diseases neurodegenerative diseases diseases characterized by neurodegeneration. Lesions are microscopic only but in chronic disease with massive involvement there may be grossly visible atrophy of affected nervous tissue. based on proteomics, and the overall importance of proteomics, the study of the thousands of cellular proteins in a human body. . . . how they interact and interconnect (1) To attach one device to another. (2) A physical port (plug, socket) or wireless port (transmitter, receiver) used to attach one device to another. . "I received messages all day from medical industry colleagues, shareholders and wanna-be shareholders," he said, noting that "everyone at Power3 was delighted to see such powerful coverage of proteomics and our very significant progress in the field. "With a photo of Ira L. Goldknopf, Ph.D., Power3's chief scientific officer, on the cover of the Chronicle's business section, there was as much focus on him than on "The Bus" . . . at least yesterday," Mr. Rash mused. "Our proteomic-based research and commercialization of early-detection diagnostic tests for cancer and neurodegenerative diseases is on-going," Mr. Rash said. "We sincerely salute and thank Brett Brune, who wrote the articles, and the Houston Chronicle, for their time and attention. Four articles appeared in the Chronicle: --"Institutes pin hopes on study of protein," http://www.chron.com/disp/story.mpl/business/3635910.html --"Area firm says its tests give early detection," http://www.chron.com/disp/story.mpl/business/3635911.html --"Proteome pro·te·ome n. The complete set of proteins that are produced by the genes of an organism. proteome the entire complement of proteins produced by a cell. vs. genome genome: see genetics. genome all the genetic content contained within an organism. An organism's genome is made up of molecules of deoxyribonucleic acid (DNA) that form long strands that are tightly wound into chromosomes, which are found in the ," http://www.chron.com/disp/story.mpl/business/3635480.html and --"Beware the (proteomics) buzzword A term that refers to the latest technology or a term that sounds catchy. If not a flash in the pan, new technologies become mainstream. For example, Java was a hot buzzword in the 1990s, but should remain a major topic for decades. ," http://www.chron.com/disp/story.mpl/business/3635441.html. Links to the articles are available on the Power3 Web site (www.power3Medical.com). About Power3 Medical Products Power3 Medical Products, Inc. (PWRM.PK) is a leading proteomics company engaged in the discovery of protein footprints, pathways, and mechanisms of diseases. Power3's patent-pending technologies are being used to develop screening and diagnostic tests for the early detection and treatment of disease, and its identified protein biomarkers, drug targets, and diagnostic tests are targeted toward markets with critical unmet un·met adj. Not satisfied or fulfilled: unmet demands. needs in areas such as breast cancer and neurodegenerative disease Neurodegenerative disease A disease in which the nervous system progressively and irreversibly deteriorates. Mentioned in: Amnesia . Power3 operates a state-of-the-art proteomics laboratory in The Woodlands (Houston), Texas. This press release contains forward-looking statements forward-looking statement A projected financial statement based on management expectations. A forward-looking statement involves risks with regard to the accuracy of assumptions underlying the projections. within the meaning of section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. With the exception of historical information contained herein, the matters discussed in this press release involve risk and uncertainties. Actual results could differ materially from those expressed in any forward-looking statement. |
|
||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion